SCIESCOPUSQ1
EXPERT OPINION ON INVESTIGATIONAL DRUGS
TAYLOR & FRANCIS LTD, United Kingdom
EXPERT OPINION ON INVESTIGATIONAL DRUGS is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1354-3784, eISSN 1744-7658. Indexed in SCIE, SCOPUS. Metrics: JIF 4.1, CiteScore 8.3, SJR 1.267, SNIP 0.90. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 4,893 papers from this journal.
CiteScore
8.30
Scopus citation metric
SJR
1.267
SCImago rank
SNIP
0.90
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1354-3784
- eISSN
- 1744-7658
- Abbreviation
- EXPERT OPIN INV DRUG
- Publisher
- TAYLOR & FRANCIS LTD
- Country
- United Kingdom
Web of Science categories
SCIEPHARMACOLOGY & PHARMACY
Scopus ASJC categories
2736 Pharmacology (medical)3004 Pharmacology
Keywords
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Multifunctional antibody-derived IL-12 mimetics: prospects of future clinical development
2026
- Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma
2026
- Investigational insights into the potential of angiotensin type II receptor agonists as therapeutics for idiopathic pulmonary fibrosis
2026
- Mass balance and absolute bioavailability of avenciguat (14C) after intravenous or oral administration in healthy male participants
2026
- KIF18A inhibition and its rising role in cancer therapy trials: from bench to bedside
2026 · 1 citations
Most cited papers
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010–2015
2017 · 547 citations
- Glioblastoma multiforme: a review of where we have been and where we are going
2009 · 537 citations
- Treatment of Acinetobacter infections.
1997 · 454 citations
- Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
2006 · 428 citations
- Renin-Angiotensin System
1992 · 422 citations